The Role of ITGAM in Systemic Lupus Erythematosus

Completed

Conditions studied: Systemic Lupus Erythematosus

In brief

Study to examine the role of ITGAM molecule in normal control subjects with known genetic variation in the ITGAM gene.

Key facts

Study ID

NCT01230112

Run by

Northwell Health

People needed

40

Starts

2009-12-01

Expected to finish

2012-04-01

Last updated by the study team

2013-07-30

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• males and females, age 18 or older, enrolled in Genotype and Phenotype Registry, in general good health
• Participants who carry the genotype of interest, based on a buccal or blood derived DNA sample

You may not qualify if…

• History of Systemic Lupus Erythematosus, rheumatoid arthritis, or other autoimmune disease
• History of cancer or lymphoma
• Current use of aspirin, prednisone, or NSAID or any immunosuppressant
• Self reported HIV

Where it is running

• Feinstein Institute for Medical Research — Manhasset, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.